Table 2.
Clinical and biochemical profiles of the 15 patients who were diagnosed with MI and positive for cTnI plasma levels
| ID | AGE (Year) | SEX | Time of sample collection after AMI (Hrs) | Glucose (mg/dl) | Creatine (mg/dl) | cTnI (ng/ml) | cMyBP-C (ng/ml) | LVEF (%) | Regional Wall Motion Abnormalities |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 56 | M | 27 | 108 | 1.25 | 6.05 | 310 | 28% | Apex is dyskinetic, AW and septum are hypokinetic |
| 2 | 51 | M | 6 | 254 | 1 | 37.5 | 26.9 | 45% | Apex is akinetic with a mobile thrombus measuring 1.2 by 1.2 cm in diameter |
| 3 | 58 | M | 41 | 153 | 1.13 | 31.6 | 557.9 | 40% | Severe hypokinesis of the apical anteriorseptum and LV apex |
| 4 | 48 | M | 52 | 95 | 1.1 | 9.09 | 146 | 28% | Severe anteroseptal hypokinesis |
| 5 | 51 | M | 62 | 125 | 0.86 | 7.77 | 36.4 | 51% | Hypokinesis of the mid to apical anteroseptum |
| 6 | 73 | F | 42 | 101 | 0.76 | 5.58 | 89 | 40% | The entire septum and AW were severely hypokinetic; the interior wall was hyperdynamic |
| 7 | 79 | M | 60 | 453 | 1.6 | 28.1 | 115.9 | 54% | Anteroseptal/apical region of LV is akinetic |
| 8 | 85 | F | 72 | 134 | 0.98 | 7.7 | 24.7 | 32% | Akinesis or severe hypokinesis of mid and apical anterior, anterior septal and lateral segments |
| 9 | 59 | M | 72 | 400 | 0.74 | 123 | 650.8 | 25% | Dyskinesis of the LV inferolateral wall |
| 10 | 85 | F | 47 | 111 | 1.28 | 55.9 | 364 | 40% | Akinesis or severe hypokinesis of mid and apical anterior, anterior septal and lateral segments |
| 11 | 91 | F | 38 | 129 | 1.66 | 6.83 | 365.1 | 30% | Dyskinesis of the LV inferolateral wall |
| 12 | 55 | M | 20 | 108 | 0.7 | 17.8 | 330 | 50% | Severe septal hypokinesis with akinetic apical anteroseptal/apical region of LV |
| 13 | 74 | F | 8 | 359 | 2.38 | 18.7 | 172.2 | 40% | Severe inferolateral hypokinesis (base to apex) |
| 14 | 86 | F | 60 | 111 | 1 | 8.4 | 90.42 | 45% | Akinetic apical anteroseptal/apical region of LV |
| 15 | 48 | M | 17 | 140 | 0.99 | 89.8 | 127.4 | 39% | Akinetic LV inferolateral wall |
Echocardiographic and clinical data of the patients were obtained using deidentified numbers. M/F indicates male/female; LVEF, LV ejection fraction, calculated as [(LVEDD-LVESD)/LVEDD*100]. Data for eleven normal healthy controls are shown in Online Supplemental Table 2. Summarized data for glucose, creatine and LVEF are available in Online Supplemental Table 3. Time of sample collection after acute myocardial infarction was calculated that interval between the time of chest pain and time of blood sample collection.